✦ LIBER ✦

P168 Hepatitis B virus reactivation in a case of non-Hodgkin's lymphoma treated with immuno-chemotherapy (including fludarabine and rituximab)

✍ Scribed by Zs. Ujj; L. Rejtö; I. Tornai; A. Kiss; B. Telek; Gy. Reményi; P. Ilonczai; M. Udvardy

Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 45 KB
Volume: 21
Category: Article
ISSN: 0268-960X
DOI: 10.1016/s0268-960x(07)70247-3

No coin nor oath required. For personal study only.

✦ Synopsis

was longer on retreatment (11 months) than at first treatment (6 months). It is of special interest, that this patient was 83 years old when treated first with radioimmunotherapy and tolerated it on both occasions without side effects or severe cytopenias. In another patient with severe accompanying diseases (grade IV obesity and schizophrenia), the ease of administration and good tolerance of radioimmunotherapy proved to be especially advantageous, treatment resulted in CRu lasting since 12 months.

📜 SIMILAR VOLUMES

Hepatitis B virus reactivation in a case

Hepatitis B virus reactivation in a case of Waldenstrom's macroglobulinemia treated with chemotherapy and Rituximab despite Adefovir prophylaxis

✍ Yasser Khaled; Amr Hanbali 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 2 views

Possible efficacy of lamivudine treatmen

Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma

✍ Y. Tsutsumi; J. Tanaka; T. Kawamura; T. Miura; H. Kanamori; S. Obara; M. Asaka; 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 106 KB

Prevention of hepatitis B reactivation w

Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy—A prospective case series

✍ Themistoklis Vassiliadis; Vassilia Garipidou; Konstantinos Tziomalos; Vassilios 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

Successful lamivudine therapy for post-c

Successful lamivudine therapy for post-chemotherapeutic fulminant hepatitis B in a hepatitis B virus carrier with non-Hodgkin's lymphoma: case report and review of the literature

✍ Y. Kawai; S. Ikegaya; M. Hata; M. Kawahito; S. Imamura; A. Yoshida; H. Tsutani; 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 19 KB

Successful long-term control with lamivu

Successful long-term control with lamivudine against reactivated hepatitis B infection following intensive chemotherapy and autologous peripheral blood stem cell transplantation in non-Hodgkin's lymphoma: Experience of 2 cases

✍ Masashi Nakagawa; Yoshifumi Simizu; Masaki Suemura; Bunzo Sato 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 3 views

## Abstract It is well documented that cytotoxic treatment in patients carrying the hepatitis B virus (HBV) enhances the risk of severe hepatic damage. Recently lamivudine has been reported to be effective in suppressing the replication of HBV under such conditions. Here we report two cases with HB